Silverarc Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$1.78M Buy
2023
Q4
Sell
2023
Q3
$8.3M Sell
2023
Q2
$14M Buy
2023
Q1
$2.72M Sell
2022
Q4
$4.64M Buy
2022
Q3
$3.95M Sell
2022
Q2
$6.91M Buy
2022
Q1
$3.09K Sell
2021
Q4
$3.27M Buy